I've always felt they should go for a registration style PII for pediatric osteosarcoma. I have no doubt there would be a huge amount of support for this indication. Maybe the company is already working on it but I don't think questions about it have come up in presentations or conference calls. I did leave another VM for Noelle as we're playing phone tag. I will bring it up.